Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dexmedetomidine on Acute Kidney Injury After Ascending Aortic Surgeries
NCT06958367Phase 1Active, not recruiting
- Sponsor
- Ain Shams University
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in acute kidney injury (AKI) (2 arms), sponsored by Ain Shams University. Primary endpoint: Incidence of Acute Kidney Injury. Started Nov 2025; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06958367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06958367.